Nanoemulsions in drug delivery: formulation to medical application.

Nanoscale oil-in-water emulsions (NEs), heterogeneous systems of two immiscible liquids stabilized by emulsifiers or surfactants, show great potential in medical applications because of their attractive characteristics for drug delivery. NEs have been explored as therapeutic carriers for hydrophobic compounds via various routes of administration. NEs provide opportunities to improve drug delivery via alternative administration routes. However, deep understanding of the NE manufacturing and functionalization fundamentals, and how they relate to the choice of administration route and pharmacological profile is still needed to ease the clinical translation of NEs. Here, we review the diversity of medical applications for NEs and how that governs their formulation, route of administration, and the emergence of increasing sophistication in NE design for specific application.

[1]  M. Colombo,et al.  Pentyl Gallate Nanoemulsions as Potential Topical Treatment of Herpes Labialis. , 2016, Journal of pharmaceutical sciences.

[2]  Ebtsam M. Abdou,et al.  Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. , 2017, International journal of pharmaceutics.

[3]  Y. Kawaoka,et al.  Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. , 2012, Vaccine.

[4]  H. Mahajan,et al.  Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting , 2014, Drug delivery.

[5]  Haibo Zhou,et al.  Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[6]  Eun Seong Lee,et al.  Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops , 2016 .

[7]  F. J. Ahmed,et al.  Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation , 2016, Drug delivery.

[8]  D. Elías,et al.  Experimental squalene adjuvant. II. Harmlessness and local reactogenity. , 2004, Vaccine.

[9]  Thomas G. Mason,et al.  New fundamental concepts in emulsion rheology , 1999 .

[10]  Sastry,et al.  Recent technological advances in oral drug delivery - a review. , 2000, Pharmaceutical science & technology today.

[11]  M. Raval,et al.  Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability , 2016, Drug delivery.

[12]  V. Pokharkar,et al.  Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency , 2017, AAPS PharmSciTech.

[13]  Christina Hoang,et al.  Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas , 2014, Drug delivery.

[14]  J. Mönkkönen,et al.  Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. , 2010, International journal of pharmaceutics.

[15]  J. Gu,et al.  Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs , 2012, International journal of nanomedicine.

[16]  P. Kulkarni,et al.  EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy , 2015, Pharmaceutical Research.

[17]  Y. Talmon,et al.  Physico-chemical characterization of Intralipid emulsions. , 1991, Biochimica et biophysica acta.

[18]  Rupesh Dudhe,et al.  Nanoemulsion: an advanced mode of drug delivery system , 2014, 3 Biotech.

[19]  R. Salvayre,et al.  Colloidal systems for drug delivery: from design to therapy. , 2012, Trends in biotechnology.

[20]  Wei Wu,et al.  Absorption, disposition and pharmacokinetics of nanoemulsions. , 2012, Current drug metabolism.

[21]  B. W. Barry,et al.  Breaching the skin's barrier to drugs , 2004, Nature Biotechnology.

[22]  J. Haensler,et al.  AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method. , 2012, Journal of pharmaceutical sciences.

[23]  J. Riess,et al.  Perfluorocarbons: Life sciences and biomedical uses Dedicated to the memory of Professor Guy Ourisson, a true RENAISSANCE man. , 2007 .

[24]  D. Mcclements,et al.  Overview of Nanoemulsion Properties: Stability, Rheology, and Appearance , 2018 .

[25]  Jinming Gao,et al.  Theranostic nanomedicine for cancer. , 2008, Nanomedicine.

[26]  K. Costa,et al.  Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform. , 2013, Chemical communications.

[27]  Yu Cao,et al.  Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFκB Signaling and Macrophage Migration , 2014, PloS one.

[28]  R. Singh,et al.  Disintegration of solid foods in human stomach. , 2008, Journal of food science.

[29]  Kamalinder K. Singh,et al.  Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. , 2008, International journal of pharmaceutics.

[30]  Chi-Tang Ho,et al.  Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. , 2008, Food chemistry.

[31]  Shweta Sharma,et al.  P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel. , 2017, Colloids and surfaces. B, Biointerfaces.

[32]  A. Podda,et al.  MF59: A safe and potent oil in water emulsion adjuvant for influenza vaccines, which induces enhanced protection against virus challenge , 2008 .

[33]  Y. Maitani,et al.  Selective delivery of folate–PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: Effect of chain length and amount of folate–PEG linker , 2008 .

[34]  Ryan F. Donnelly,et al.  Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery , 2007 .

[35]  C. Ehrhardt,et al.  Inhaled Liposomes–Current Strategies and Future Challenges , 2008 .

[36]  J. Baldridge,et al.  Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. , 1999, Methods.

[37]  S. Wilton,et al.  Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy , 2015, RNA biology.

[38]  D. Scherman,et al.  Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. , 2012, International journal of pharmaceutics.

[39]  Amit Singh,et al.  Nanoemulsions in Translational Research—Opportunities and Challenges in Targeted Cancer Therapy , 2014, AAPS PharmSciTech.

[40]  T. Vandamme,et al.  Pulmonary drug delivery systems: recent developments and prospects. , 2002, Critical reviews in therapeutic drug carrier systems.

[41]  Jason R McCarthy,et al.  The future of theranostic nanoagents. , 2009, Nanomedicine.

[42]  S. Onoue,et al.  Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  H. Teixeira,et al.  Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. , 2007, International journal of pharmaceutics.

[44]  A. Thomas,et al.  Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02 , 2008, PloS one.

[45]  Noraini Ahmad,et al.  Nanoemulsion as a topical delivery system of antipsoriatic drugs , 2016 .

[46]  R. Farinotti,et al.  Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. , 2003, International journal of pharmaceutics.

[47]  D. Mcclements,et al.  General Aspects of Nanoemulsions and Their Formulation , 2018 .

[48]  Ishan S. Shah,et al.  Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation , 2014, Drug development and industrial pharmacy.

[49]  W. Powderly,et al.  Amphotericin B: current understanding of mechanisms of action , 1990, Antimicrobial Agents and Chemotherapy.

[50]  F. Sonvico,et al.  Opportunities and challenges for the nasal administration of nanoemulsions. , 2015, Current topics in medicinal chemistry.

[51]  S. Ascarateil,et al.  Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines , 2002, Expert review of vaccines.

[52]  J. Janjic,et al.  Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. , 2015, Clinical immunology.

[53]  Z. Duan,et al.  Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. , 2011, Molecular pharmaceutics.

[54]  A. Kabalnov Ostwald Ripening and Related Phenomena , 2001 .

[55]  S. Caruthers,et al.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions , 2010, Angiogenesis.

[56]  Connie B. Chang,et al.  Nanoemulsions: formation, structure, and physical properties , 2006 .

[57]  Amir Amani,et al.  Design and evaluation of oral nanoemulsion drug delivery system of mebudipine , 2016, Drug delivery.

[58]  J. Ali,et al.  Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs , 2012, Expert opinion on drug delivery.

[59]  F. Liu,et al.  Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging. , 2014, Nanomedicine.

[60]  A. Håkansson,et al.  General Principles of Nanoemulsion Formation by High-Energy Mechanical Methods , 2018 .

[61]  A. Puertas,et al.  Nanoemulsion stability: experimental evaluation of the flocculation rate from turbidity measurements. , 2012, Advances in colloid and interface science.

[62]  A. Allison,et al.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. , 1986, Journal of immunological methods.

[63]  A. Misra,et al.  Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting , 2008, Journal of drug targeting.

[64]  S. K. Ghosal,et al.  Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems. , 2004, Indian journal of experimental biology.

[65]  Theresa M Allen,et al.  Advantages of liposomal delivery systems for anthracyclines. , 2004, Seminars in oncology.

[66]  R. Yunes,et al.  Evaluation of Anti-herpetic and Antioxidant Activities, and Cytotoxic and Genotoxic Effects of Synthetic Alkyl-Esters of Gallic Acid , 2005, Arzneimittelforschung.

[67]  R. Strickley Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[68]  R. Panchagnula,et al.  Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. , 2007, The Journal of investigative dermatology.

[69]  Tushar K. Vyas,et al.  Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations. , 2008, Journal of pharmaceutical sciences.

[70]  S. Majumdar,et al.  Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.

[71]  D. Mcclements,et al.  Food-Grade Nanoemulsions: Formulation, Fabrication, Properties, Performance, Biological Fate, and Potential Toxicity , 2011, Critical reviews in food science and nutrition.

[72]  Yan-fang Yang,et al.  Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition. , 2016, International journal of pharmaceutics.

[73]  Andrew R. Martin,et al.  Nebulizers for drug delivery to the lungs , 2015, Expert opinion on drug delivery.

[74]  Michael C. Kolios,et al.  Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[75]  Chandrakantsing V. Pardeshi,et al.  Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting , 2013, Expert opinion on drug delivery.

[76]  A. Middelberg,et al.  Foaming properties of a peptide designed to form stimuli-responsive interfacial films. , 2006, Soft matter.

[77]  Amrish Kumar,et al.  Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method , 2017, Artificial cells, nanomedicine, and biotechnology.

[78]  Shobhona Sharma,et al.  Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. , 2012, International journal of pharmaceutics.

[79]  V. Kishan,et al.  Development and in vitro cytotoxic evaluation of parenteral docetaxel lipid nanoemulsions for application in cancer treatment. , 2010, PDA journal of pharmaceutical science and technology.

[80]  Y. Pathak,et al.  In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions. , 1991, Journal of pharmaceutical sciences.

[81]  D. Barros,et al.  Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats , 2016, Nanotechnology.

[82]  K. Burgess,et al.  Small Molecules for Active Targeting in Cancer , 2016, Medicinal research reviews.

[83]  Olav Haraldseth,et al.  The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. , 2012, ACS nano.

[84]  H. Chrystyn,et al.  Evaluation of a Nanoemulsion-Based Formulation for Respiratory Delivery of Budesonide by Nebulizers , 2010, AAPS PharmSciTech.

[85]  K. Wasan,et al.  Cyclosporine A: A Review of Current Oral and Intravenous Delivery Systems , 2007, Drug development and industrial pharmacy.

[86]  D. Paolino,et al.  Colloidal carriers for the enhanced delivery through the skin , 2008 .

[87]  David Julian McClements,et al.  Edible nanoemulsions: fabrication, properties, and functional performance , 2011 .

[88]  N. Garçon,et al.  From discovery to licensure, the Adjuvant System story , 2016, Human vaccines & immunotherapeutics.

[89]  D. Vaughn,et al.  Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion , 2012, Expert review of vaccines.

[90]  D A Groneberg,et al.  Fundamentals of pulmonary drug delivery. , 2003, Respiratory medicine.

[91]  Farooq Ali Khan,et al.  Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[92]  H. Junginger,et al.  Cationic submicron emulsions for pulmonary DNA immunization. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[93]  I. Lifshitz,et al.  The kinetics of precipitation from supersaturated solid solutions , 1961 .

[94]  D. Mcclements Years of Advancing Food Science , and Preparing for the Next 75 Nanoscale Nutrient Delivery Systems for Food Applications : Improving Bioactive Dispersibility , Stability , and Bioavailability , 2015 .

[95]  M. Knuf,et al.  Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. , 2009, Vaccine.

[96]  S. B. Tiwari,et al.  Preparation and In Vitro Characterization of Multifunctional Nanoemulsions for Simultaneous MR Imaging and Targeted Drug Delivery , 2006 .

[97]  Anton P. J. Middelberg,et al.  Towards designer nanoemulsions for precision delivery of therapeutics , 2014 .

[98]  J. Hansen,et al.  Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. , 1996, Vaccine.

[99]  Hiroshi Saito,et al.  The effect of temperature on the phase equilibria and the types of dispersions of the ternary system composed of water, cyclohexane, and nonionic surfactant , 1968 .

[100]  V. Patravale,et al.  Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. , 2009, Journal of biomedical nanotechnology.

[101]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[102]  M. Simionescu,et al.  P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation , 2016, Mediators of inflammation.

[103]  O Sonneville-Aubrun,et al.  Nanoemulsions: a new vehicle for skincare products. , 2004, Advances in colloid and interface science.

[104]  A. Allison Squalene and squalane emulsions as adjuvants. , 1999, Methods.

[105]  C. Fox Squalene Emulsions for Parenteral Vaccine and Drug Delivery , 2009, Molecules.

[106]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[107]  A. Ahad,et al.  Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box–Behnken design optimization and pharmacokinetic evaluation , 2016 .

[108]  Pramod K. Gupta,et al.  Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis , 2014, Expert opinion on drug delivery.

[109]  G. Gutiérrez-López,et al.  Nanoencapsulation: A New Trend in Food Engineering Processing , 2010 .

[110]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[111]  A. Ali,et al.  scFv Antibody: Principles and Clinical Application , 2012, Clinical & developmental immunology.

[112]  T. Hitchens,et al.  A novel probe for the non-invasive detection of tumor-associated inflammation , 2013, Oncoimmunology.

[113]  G. Ott,et al.  Development of Vaccine Adjuvants: A Historical Perspective , 2006 .

[114]  Shobhit Kumar,et al.  Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation , 2016, Nanotechnology.

[115]  R. Nicolosi,et al.  Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. , 2008, International journal of pharmaceutics.

[116]  Y. Goto,et al.  Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions. , 2008, Colloids and surfaces. B, Biointerfaces.

[117]  J. Ward,et al.  Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity. , 1997, Vaccine.

[118]  Hélder D. Silva,et al.  Nanoemulsions for Food Applications: Development and Characterization , 2012, Food and Bioprocess Technology.

[119]  H. Teixeira,et al.  Development and characterization of parenteral nanoemulsions containing thalidomide. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[120]  Roger Y. Tsien,et al.  Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging , 2016, Nature materials.

[121]  M. Zier,et al.  Inspiratory flow resistance of marketed dry powder inhalers (DPI) , 2014 .

[122]  Thomas Delmas,et al.  How to prepare and stabilize very small nanoemulsions. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[123]  A. Middelberg,et al.  Receptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assembly. , 2013, Small.

[124]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[125]  Huibi Xu,et al.  Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. , 2008, International journal of pharmaceutics.

[126]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[127]  M. Ashokkumar,et al.  The use of ultrasonics for nanoemulsion preparation , 2008 .

[128]  N. Groth,et al.  MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. , 2009, Vaccine.

[129]  N. Shibata,et al.  A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. , 2001, Life sciences.

[130]  J. Haensler,et al.  Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. , 2015, International journal of pharmaceutics.

[131]  R. Rappuoli,et al.  Molecular and cellular signatures of human vaccine adjuvants , 2008, Proceedings of the National Academy of Sciences.

[132]  K. Hayat,et al.  An Overview of Ultrasound-Assisted Food-Grade Nanoemulsions , 2013, Food Engineering Reviews.

[133]  J Christian Virchow Guidelines versus clinical practice--which therapy and which device? , 2004, Respiratory medicine.

[134]  W. Denny,et al.  Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer Cells , 2012, Pharmaceutical Research.

[135]  K. Hörmann,et al.  Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[136]  P. Barthélémy,et al.  Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging. , 2017, International journal of pharmaceutics.

[137]  A. Elhissi,et al.  Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. , 2012, International journal of pharmaceutics.

[138]  S. Bertholet,et al.  New horizons in adjuvants for vaccine development. , 2009, Trends in immunology.

[139]  A. Hoffman,et al.  Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[140]  S. Tang,et al.  Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. , 2012, International journal of pharmaceutics.

[141]  F. Behar-Cohen,et al.  Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[142]  P van Hoogevest,et al.  MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. , 1995, Pharmaceutical biotechnology.

[143]  A. Soubani,et al.  The clinical spectrum of pulmonary aspergillosis. , 2002, Chest.

[144]  R. Löbenberg,et al.  Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.

[145]  Nazrul Islam,et al.  Dry powder inhalers (DPIs)--a review of device reliability and innovation. , 2008, International journal of pharmaceutics.

[146]  Patrick S Doyle,et al.  Nanoemulsions: formation, properties and applications. , 2016, Soft matter.

[147]  M. J. García,et al.  Formation of water-in-oil (W/O) nano-emulsions in a water/mixed non-ionic surfactant/oil systems prepared by a low-energy emulsification method , 2004 .

[148]  S. Chi,et al.  Transdermal delivery of ketoprofen using microemulsions. , 2001, International journal of pharmaceutics.

[149]  C. Solans,et al.  Nano-emulsions: Formation by low-energy methods , 2012 .

[150]  Y. Maa,et al.  Performance of sonication and microfluidization for liquid-liquid emulsification. , 1999, Pharmaceutical development and technology.

[151]  V. Sondak,et al.  Melacine®: an allogeneic melanoma tumor cell lysate vaccine , 2003, Expert review of vaccines.

[152]  Min Wu,et al.  Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy , 2015, Theranostics.

[153]  J. Baker,et al.  Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats , 2015, Human vaccines & immunotherapeutics.

[154]  M. Basri,et al.  Formulation optimization of palm kernel oil esters nanoemulsion-loaded with chloramphenicol suitable for meningitis treatment. , 2013, Colloids and surfaces. B, Biointerfaces.

[155]  D. Mcclements,et al.  Formation of Food-Grade Nanoemulsions Using Low-Energy Preparation Methods: A Review of Available Methods. , 2016, Comprehensive reviews in food science and food safety.

[156]  S. Talegaonkar,et al.  Nanoemulsion in Drug Targeting , 2015 .

[157]  J. Salk,et al.  Direction of research on vaccination against influenza; new studies with immunologic adjuvants. , 1951, American journal of public health and the nation's health.

[158]  H. Warenius Technological challenges of theranostics in oncology. , 2009, Expert opinion on medical diagnostics.

[159]  A. Steiner,et al.  Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer , 2018, Drug delivery.

[160]  S. Ganta,et al.  Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion , 2009, Journal of drug targeting.

[161]  Stephen T. C. Wong,et al.  Cancer Theranostics: An Introduction , 2014 .

[162]  D. Elías,et al.  Experimental squalene adjuvant. I. Preparation and testing of its effectiveness. , 2004, Vaccine.

[163]  A. Middelberg,et al.  Insights into the role of protein molecule size and structure on interfacial properties using designed sequences , 2013, Journal of The Royal Society Interface.